Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Advances in tumor angiogenesis - Dendritic cells co-opted to the dark side

30.08.2004


Immune cells transform into blood-vessel cells in ovarian cancer




Researchers at the University of Pennsylvania School of Medicine discovered that in ovarian cancer immune cells can change into blood-vessel cells, and eventually promote the life-sustaining vasculature of the tumor. These findings were initially observed in a mouse model of ovarian cancer that the investigators generated and then confirmed in human ovarian cancer. This work may lead to new approaches to fighting solid tumors.

George Coukos, MD, PhD, and his team, Jose Conejo-Garcia, MD, PhD, and Fabian Benencia, PhD, all investigators in the Abramson Cancer Center and the Center for Research in Women’s Health and Reproduction, report their findings in this week’s online publication and the September issue of Nature Medicine.


"These results clearly deal with ovarian cancer, but we think that the concept is applicable to solid tumors in general," says Coukos. Ovarian cancer is the leading killer among gynecologic cancers, causing about 25,000 new cases a year and about 15,000 deaths annually in the U.S. "One of the problems is that it’s diagnosed late and we don’t have effective treatments for it.

"Dendritic cells play a central role in the generation of antitumor immune response," says Coukos. "As a result, it was believed that these were mostly good players in inducing tumor rejection." But when dendritic cells are part of the tumor microenvironment, instead of stimulating an immune response, they deviate from the program and are co-opted into tumor angiogenesis. "When the dendritic cell precursors are put in the tumor context they form blood vessels that are functional," notes Conejo-Garcia. In a mouse model in which ovarian tumors expressed high amounts of the proteins beta-defensin and VEGF-A, dendritic cell precursors were attracted to the tumor, where they turned into an endothelial-like cell type. Endothelial cells are the cells forming the inner lining of blood vessels. They are critical for building tumor blood vessels and promoting tumor growth.

For tumors to survive there needs to be a balance between factors that promote tumor growth such as angiogenesis and factors that control tumor growth such as immune response. Researchers have always considered these as two separate systems. "The breakthrough that this work provides is that there is indeed a tremendous interaction between these processes," says Coukos.

VEGF-A is the key for the transformation of dendritic cells, according to this study. VEGF proteins are ligands produced in the tumor that induce survival and proliferation of endothelial cells. When VEGF-A is overexpressed in tumors, dendritic cells change into endothelial cells, but in the absence of high VEGF-A levels or when VEGF-A is inhibited, the tendency of dendritic cells to convert is reversed. "I think what is fascinating in terms of biology is the plasticity that this cell has depending on its microenvironment," says Benencia.

It is well established that VEGF-A is the master switch for tumor angiogenesis, with a dose-dependent effect: in this case, dendritic cells were converted into endothelial-like cells only in the presence of high VEGF-A levels. "The levels of VEGF-A generated in our animal model of ovarian cancer resemble those seen in human ovarian cancer," says Coukos. "We have recapitulated what happens in human tumors." Thus, VEGF promotes tumor growth not only through angiogenesis but also through suppression of antitumor immune response, because these dendritic cells lose their ability to induce tumor rejection, which in turn may explain why some tumors are tolerated immunologically.

"We are the first to show that dendritic cell precursors in tumors build blood vessels," says Coukos. "This has previously been seen in vitro, where others have shown that monocytes or dendritic cells can turn into something that looks like endothelial cells, but no one has been able to demonstrate that this could happen in vivo and show its contribution to pathology and physiology."

The work has also revealed that the bone marrow – via dendritic cell precursors, which are produced in the marrow – is involved in angiogenesis. This observation raises clinically important questions as to the effects of supporting the bone marrow with growth factors during chemotherapy. Dendritic cells have surface molecules called CCR6, which are receptors for beta defensins and other molecules with chemoattracting properties. The team discovered that beta-defensins produced by the tumor attract dendritic cells to the tumor and thus contribute to angiogenesis. The team injected an antibody to CCR6 with an attached toxin that inactivates ribosomes. The toxin is internalized only by cells expressing CCR6, ultimately resulting in cell death. Selective killing of CCR6-expressing cells led tumors to shrink. "This has opened a door to a new therapeutic approach, which was not envisioned before," says Coukos.

Karen Kreeger | EurekAlert!
Further information:
http://www.upenn.edu

More articles from Life Sciences:

nachricht Antimicrobial substances identified in Komodo dragon blood
23.02.2017 | American Chemical Society

nachricht New Mechanisms of Gene Inactivation may prevent Aging and Cancer
23.02.2017 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

From rocks in Colorado, evidence of a 'chaotic solar system'

23.02.2017 | Physics and Astronomy

'Quartz' crystals at the Earth's core power its magnetic field

23.02.2017 | Earth Sciences

Antimicrobial substances identified in Komodo dragon blood

23.02.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>